Literature DB >> 33433840

Minimal Clinically Important Difference, Substantial Clinical Benefit, and Patient Acceptable Symptom State of Outcome Measures Relating to Shoulder Pathology and Surgery: a Systematic Review.

Favian Su1, Sachin Allahabadi1, Dale N Bongbong2, Brian T Feeley1, Drew A Lansdown3.   

Abstract

PURPOSE OF THE REVIEW: To provide a comprehensive summary of available literature on the minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) of patient-reported outcome measures (PROMs) for various shoulder conditions and outcomes and to identify factors that influence these metrics. RECENT
FINDINGS: Over the past 2 years, there has been an increasing interest in utilizing MCID, SCB, and PASS as a gauge to evaluate the success of an intervention for shoulder conditions. Efforts at calculating these thresholds have yielded multiple and inconsistent values and are further compounded by the proliferation of different PROMs in the shoulder literature. The MCID, SCB, and PASS values of shoulder PROMs vary widely with study-specific characteristics, including patient demographics, shoulder pathology, treatment, shoulder instrument, study methodology, and calculation method. The differences in these factors are not inconsequential and could lead to large discrepancies in threshold values. It is crucial that clinicians are mindful of these variables when designing future studies to calculate these metrics or when utilizing previously published values to determine the success of an intervention.

Entities:  

Keywords:  Minimal clinical important difference; Outcomes; Patient acceptable symptom state; Shoulder; Substantial clinical benefit

Year:  2021        PMID: 33433840     DOI: 10.1007/s12178-020-09684-2

Source DB:  PubMed          Journal:  Curr Rev Musculoskelet Med        ISSN: 1935-9748


  54 in total

1.  Minimal clinically important difference (MCID)--adding meaning to statistical inference.

Authors:  Linda S Chan
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

2.  Feeling good rather than feeling better matters more to patients.

Authors:  Florence Tubach; Maxime Dougados; Bruno Falissard; Gabriel Baron; Isabelle Logeart; Philippe Ravaud
Journal:  Arthritis Rheum       Date:  2006-08-15

Review 3.  A point of minimal important difference (MID): a critique of terminology and methods.

Authors:  Madeleine T King
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-04       Impact factor: 2.217

4.  Minimal clinically important difference: defining what really matters to patients.

Authors:  Anna E McGlothlin; Roger J Lewis
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

5.  Measurement of health status. Ascertaining the minimal clinically important difference.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1989-12

6.  Metabolism of ethylmalic acids by Pseudomonas aeruginosa.

Authors:  R Rabin; I I Salamon; A S Bleiweis; J Carlin; S J Ajl
Journal:  Biochemistry       Date:  1968-01       Impact factor: 3.162

7.  Minimal Clinically Important Difference of Shoulder Outcome Measures and Diagnoses: A Systematic Review.

Authors:  Dominique I Dabija; Nitin B Jain
Journal:  Am J Phys Med Rehabil       Date:  2019-08       Impact factor: 2.159

8.  Defining substantial clinical benefit following lumbar spine arthrodesis.

Authors:  Steven D Glassman; Anne G Copay; Sigurd H Berven; David W Polly; Brian R Subach; Leah Y Carreon
Journal:  J Bone Joint Surg Am       Date:  2008-09       Impact factor: 5.284

9.  How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.

Authors:  Jan L Brozek; Gordon H Guyatt; Holger J Schünemann
Journal:  Health Qual Life Outcomes       Date:  2006-09-27       Impact factor: 3.186

10.  Minimal important differences for improvement in shoulder condition patient-reported outcomes: a systematic review to inform a BMJ Rapid Recommendation.

Authors:  Qiukui Hao; Tahira Devji; Dena Zeraatkar; Yuting Wang; Anila Qasim; Reed A C Siemieniuk; Per Olav Vandvik; Tuomas Lähdeoja; Alonso Carrasco-Labra; Thomas Agoritsas; Gordon Guyatt
Journal:  BMJ Open       Date:  2019-02-20       Impact factor: 2.692

View more
  2 in total

1.  Why patients fail to achieve a Patient Acceptable Symptom State (PASS) after total shoulder arthroplasty?

Authors:  Elliott W Cole; Samuel G Moulton; Brian C Werner; Patrick J Denard
Journal:  JSES Int       Date:  2021-11-17

2.  Return to Sport After Shoulder Stabilization Procedures: A Criteria-Based Testing Continuum to Guide Rehabilitation and Inform Return-to-Play Decision Making.

Authors:  Thomas Otley; Heather Myers; Brian C Lau; Dean C Taylor
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.